Research and analysis

Herpes zoster (shingles) immunisation programme 2016 to 2017: evaluation report

Evaluation of the fourth year of the shingles vaccination programme in England from 2016 to 2017.

From:
Public Health England
Published
15 December 2017

Documents

Ref: PHE Publications gateway number 2017646

PDF, 623 KB, 15 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

138 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 196 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MS Excel Spreadsheet, 115 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 276 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

MS Excel Spreadsheet, 117 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The shingles vaccination programme aims to reduce the incidence and severity of shingles in those targeted by the programme by boosting individuals鈥� pre-existing varicella zoster virus immunity.

This report highlights the lower coverage achieved in the routine and catch-up cohort in 2016 to 2017 compared with previous years. GPs are urged to continue to offer vaccinations to these cohorts as per current guidance, to improve protection in these age groups.

In the fourth year of the programme (2016 to 2017), the vaccine was offered to adults:

  • aged 70 years on 1 September 2016 (born between 2 September 1945 and 1 September 1946)
  • aged 78 years on 1 September 2016 (born between 2 September 1937 and 1 September 1938)

The eligibility criteria for shingles vaccine changed from 1 April 2017.

Last year鈥檚 report for comparison.

Updates to this page

Published 15 December 2017

Sign up for emails or print this page

Related content